300 related articles for article (PubMed ID: 25894641)
1. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
Lal D; Manocha S; Ray A; Vijayan VK; Kumar R
J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641
[TBL] [Abstract][Full Text] [Related]
2. Doxofylline is not just another theophylline!
Matera MG; Page C; Cazzola M
Int J Chron Obstruct Pulmon Dis; 2017; 12():3487-3493. PubMed ID: 29255355
[TBL] [Abstract][Full Text] [Related]
3. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.
Shukla D; Chakraborty S; Singh S; Mishra B
Expert Opin Pharmacother; 2009 Oct; 10(14):2343-56. PubMed ID: 19678793
[TBL] [Abstract][Full Text] [Related]
4. The effect of doxofylline in asthma and COPD.
Cazzola M; Matera MG
Respir Med; 2020 Apr; 164():105904. PubMed ID: 32094104
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease.
Wang T; Luo G; Hu Y; Li F; Ma J; Wang J; Zuo P; Xiong W; Liu X; Zhao J; Xiong S; Zhang Z; Li C; Zhao S; Sun J; Xu Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):614. PubMed ID: 22038349
[TBL] [Abstract][Full Text] [Related]
7. Impact of doxofylline in COPD: A pairwise meta-analysis.
Cazzola M; Calzetta L; Rogliani P; Page C; Matera MG
Pulm Pharmacol Ther; 2018 Aug; 51():1-9. PubMed ID: 29705620
[TBL] [Abstract][Full Text] [Related]
8. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M
Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705
[TBL] [Abstract][Full Text] [Related]
9. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.
Calzetta L; Matera MG; Goldstein MF; Fairweather WR; Howard WW; Cazzola M; Rogliani P
Pulm Pharmacol Ther; 2020 Feb; 60():101883. PubMed ID: 31884206
[TBL] [Abstract][Full Text] [Related]
10. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease].
Xu YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):319-22. PubMed ID: 15266839
[TBL] [Abstract][Full Text] [Related]
11. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ;
Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682
[TBL] [Abstract][Full Text] [Related]
12. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
Santra CK
J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
[TBL] [Abstract][Full Text] [Related]
13. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety profile of xanthines in COPD: a network meta-analysis.
Cazzola M; Calzetta L; Barnes PJ; Criner GJ; Martinez FJ; Papi A; Gabriella Matera M
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29720510
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on doxofylline injection in treatment of children with acute asthma attacks].
Zhang JX; Lin HQ; Chen JS
Zhonghua Er Ke Za Zhi; 2004 Feb; 42(2):143-4. PubMed ID: 15059495
[No Abstract] [Full Text] [Related]
16. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
Dini FL; Cogo R
Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710
[TBL] [Abstract][Full Text] [Related]
17. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma.
Bagnato GF
Eur Rev Med Pharmacol Sci; 1999; 3(6):255-60. PubMed ID: 11261736
[TBL] [Abstract][Full Text] [Related]
19. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
20. [Theophylline in treatment of bronchial obstructive diseases].
Rogala B
Wiad Lek; 1998; 51(3-4):117-21. PubMed ID: 9658984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
